Company: LNAI
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001731122-25-000765
Chunk: 70

Company: Lunai Bioworks Inc.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 1
Chunk 70
---

remains pending.

On June 21, 2024, the Company filed suit against Weird
Science, Wittekind, and certain trusts in connection with the February 16, 2018 merger involving the Company and two companies closely
associated with Gumrukcu. In the complaint, the Company alleges that Gumrukcu and others deliberately and fraudulently concealed a murder-for-hire
scheme from the Company in order to induce the Company to enter into the merger agreement, which resulted in the defendants receiving
shares and compensation. The Company asserts claims for fraudulent concealment, equitable fraud, unjust enrichment, and civil conspiracy
and seeks, inter alia, equitable relief, including, but not limited to, return to the Company any shares received in connection
with the merger, and damages. On October 1, 2024, the defendants moved to dismiss the complaint and a hearing has been scheduled for June
25, 2025.

Item 1A. Risk Factors.

As a “smaller reporting company”
as defined by Rule 12b-2 of the Securities Exchange Act of 1934, the Company is not required to provide the information required by this
Item.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

None.

Item 3. Defaults Upon Senior Securities. 

None.

Item 4. Mine Safety Disclosures. 

Not applicable.

Item 5. Other Information.

Insider Trading Plans

During the quarter ended December 31, 2024, no director
or Section 16 officer adopted, modified, or terminated any “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading
arrangement” (in each case, as defined in Item 408(a) of Regulation S-K).

40

Item 6. Exhibits.

Exhibits required by Item 601 of Regulation S-K:

    Exhibit No.
     
    Description 

     2.1
     
    Agreement and Plan of Merger, dated February 26, 2025, by and among Renovaro, Inc, Renovaro Acquisition Sub and Biosymetrics, Inc. (incorporated by reference to Exhibit 2.1 to the Company’s Form 8-K filed with the SEC on February 28, 2025)

    3.1 
     
    Certificate of Incorporation, as amended (incorporated by reference to Exhibit 3.1 to the